Work

Divalproex in the Treatment of Impulsive Aggression: Efficacy in Cluster B Personality Disorders

Year: 2003

Type: article

Study designs: Randomized Controlled Trial, Clinical Trial

Source: Neuropsychopharmacology

DOI: 10.1038/sj.npp.1300153

Authors: Eric Hollander, Katherine A Tracy, Alan C Swann, Emil F Coccaro, Susan L McElroy, Patricia Wozniak, Kenneth W Sommerville, Charles B Nemeroff

Institutions: Icahn School of Medicine at Mount Sinai, University of Illinois Chicago, Abbott (United States), The University of Texas Health Science Center at Houston, University of Chicago, University of Cincinnati, Emory University

Language: English

Topic: Personality Disorders and Psychopathology

Subfield: Clinical Psychology

Field: Psychology

Domain: Social Sciences

SDG: Good health and well-being

Open Access status: closed

Funders: Abbott Laboratories, Bristol-Myers Squibb, Eli Lilly and Company, Pfizer, AstraZeneca, GlaxoSmithKline, Sanofi, McLean Hospital, Emory University, University of Minnesota, University of South Carolina, National Alliance for Research on Schizophrenia and Depression, ACADIA Pharmaceuticals, Neurocrine Biosciences, Pfizer Pharmaceuticals, National Center for PTSD, U.S. Department of Veterans Affairs, National Institute of Mental Health, Janssen Pharmaceuticals, UCB Pharma

OpenAlex ID: W2015030946

FWCI: 21.94

Cites: 57

Cited by: 280

Related to: 10